Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Farmers Insurance
Chinese Patent Office
Express Scripts
Queensland Health
Merck
Moodys
Healthtrust

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022113

« Back to Dashboard
NDA 022113 describes ADVIL MULTI-SYMPTOM COLD & FLU, which is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. Additional details are available on the ADVIL MULTI-SYMPTOM COLD & FLU profile page.

The generic ingredient in ADVIL MULTI-SYMPTOM COLD & FLU is chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride profile page.

Summary for NDA: 022113

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022113

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL ALLERGY AND CONGESTION RELIEF
chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride
TABLET;ORAL 022113 NDA Pfizer Consumer Healthcare 0573-0196 0573-0196-01 50 PACKET in 1 TRAY (0573-0196-01) > 1 TABLET, COATED in 1 PACKET
ADVIL ALLERGY AND CONGESTION RELIEF
chlorpheniramine maleate; ibuprofen; phenylephrine hydrochloride
TABLET;ORAL 022113 NDA Pfizer Consumer Healthcare 0573-0196 0573-0196-10 1 BLISTER PACK in 1 CARTON (0573-0196-10) > 10 TABLET, COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength4MG;200MG;10MG
Approval Date:Dec 21, 2011TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength4MG;200MG;10MG
Approval Date:Apr 28, 2017TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Fuji
Daiichi Sankyo
UBS
Harvard Business School
Queensland Health
Federal Trade Commission
Moodys
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot